Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients

Atherosclerosis

Volumn 192, Issue 2, 2007, Pages 401-406

  Kim, Jung Sun ^a   Kang, Tae Soo ^c   Kim, Jin Bae ^a   Seo, Hye Sun ^a   Park, Sungha ^a,b   Kim, Changsoo ^a   Ko, Young Guk ^a   Choi, Donghoon ^a   Jang, Yangsoo ^a,b   Chung, Namsik ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Dankook University   (South Korea)

Author keywords

Arteriosclerosis; C reactive protein; Hypertension

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTERIOSCLEROSIS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENDER; HEART RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; ANTIHYPERTENSIVE AGENTS; ARTERIES; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; C-REACTIVE PROTEIN; ELASTICITY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PULSATILE FLOW; REGRESSION ANALYSIS;

EID: 34248174340     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.05.025     Document Type: Article

References (31)

1. Franklin S.S., Gustin IV W., Wong N.D., et al. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 96 (1997) 308-315
2. Laurent S., Katsahian S., Fassot C., et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke 34 (2003) 1203-1206
3. Domanski M.J., Mitchell G.F., Norman J.E., et al. Independent prognostic information provided by sphygmomanometrically determined pulse pressure and mean arterial pressure in patients with left ventricular dysfunction. J Am Coll Cardiol 33 (1999) 951-958
4. Abramson J.L., Weintraub W.S., and Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy US adults. Hypertension 39 (2002) 197-202
5. Blacher J., Guerin A.P., Pannier B., et al. Impact of aortic stiffness on survival in end-stage renal disease. Circulation 99 (1999) 2434-2439
6. Laurent S., Boutouyrie P., Asmar R., et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37 (2001) 1236-1241
7. Cruickshank K., Riste L., Anderson S.G., et al. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function?. Circulation 106 (2002) 2085-2090
8. Boutouyrie P., Tropeano A.I., Asmar R., et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients. Hypertension 39 (2002) 10-15
9. Sutton-Tyrrell K., Najjar S.S., Boudreau R.M., et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation 111 (2005) 3384-3390
10. Ichihara A., Hayashi M., Koura Y., et al. Long term effects of intensive blood pressure lowering on arterial wall stiffness in hypertensive patients. Am J Hypertens 16 (2003) 959-965
11. Chae C.U., Lee R.T., Rifai N., and Ridker P.M. Blood pressure and inflammation in apparently healthy men. Hypertension 38 (2001) 399-403
12. Hashimoto H., Kitagawa K., Hougaku H., Etani H., and Hori M. Relationship between C-reactive protein and progression of early carotid atherosclerosis in hypertensive subjects. Stroke 35 (2004) 1625-1630
13. Mahmud A., and Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 46 (2005) 1118-1122
14. Nagano M., Nakamura M., Sato K., et al. Association between serum C-reactive protein levels and pulse wave velocity: a population-based cross-sectional study in a general population. Atherosclerosis 180 (2005) 189-195
15. Mattace-Raso F.U., van der Cammen T.J., van der Meer I.M., et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 176 (2004) 111-116
16. Munakata M., Ito N., Nunokawa T., and Yoshinaga K. Utility of automated brachial ankle pulse wave velocity measurements in hypertensive patients. Am J Hypertens 16 (2003) 653-657
17. Kimoto E., Shoji T., Shinohara K., et al. Preferential stiffening of central over peripheral arteries in type 2 diabetes. Diabetes 52 (2003) 448-452
18. Yamashina A., Tomiyama H., Takeda K., et al. Validity, reproducibility, and clinical significance of non invasive brachial-ankle pulse wave velocity measurement. Hypertens Res 25 (2002) 359-364
19. Ridker P.M., Rifai N., Rose L., Buring J.E., and Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 347 (2002) 1557-1565
20. Ridker P.M., Cannon C.P., Morrow D., et al. Pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 (PROVE IT-TIMI 22) investigators. C-reactive protein levels and outcomes after statin therapy. N Engl J Med 352 (2005) 20-28
21. Kostis J., Lawrence-Nelson J., Ranjan R., et al. Association of increased pulse pressure with the development of heart failure in SHEP. Systolic Hypertension in the Elderly (SHEP) Cooperative Research Group. Am J Hypertens 14 (2001) 798-803
22. Scuteri A., Najjar S.S., Muller D.C., et al. Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol 43 (2004) 1388-1395
23. Pasceri V., Willerson J.T., and Yeh E.T. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102 (2000) 2165-2168
24. Pasceri V., Cheng J.S., Willerson J.T., and Yeh E.T. Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103 (2001) 2531-2534
25. Mahmud A., and Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens 15 (2002) 321-325
26. Takeda T., Hoshida S., Nishino M., et al. Relationship between effects of statins, aspirin and angiotension II modulators on high-sensitive C-reactive protein levels. Atherosclerosis 169 (2003) 155-158
27. Yasmin, McEniery C.M., Wallace S., et al. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol 24 (2004) 969-974
28. London G.M., Marchais S.J., Guerin A.P., et al. Inflammation, arteriosclerosis, and cardiovascular therapy in hemodialysis patients. Kidney Int Suppl 84 (2003) S88-S93
29. Wong M., Toh L., Wilson A., et al. Reduced arterial elasticity in rheumatoid arthritis and the relationship to vascular disease risk factors and inflammation. Arthritis Rheum 48 (2003) 81-89
30. Aso K., Miyata M., Kubo T., et al. Brachial-ankle pulse wave velocity is useful for evaluation of complication in type 2 diabetic patients. Hypertens Res 26 (2003) 807-813
31. Ferrier K.E., Muhlmann M.H., Baguet J.P., et al. Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. J Am Coll Cardiol 39 (2002) 1020-1025